AIM2 and cancer: Upstream sensors like ZBP1, AIM2, and RIPK1, along with regulators identified in cancer-related PANoptosis studies, such as IRF1, ADAR, MAP3K7, and NFS1, were also incorporated for their significant regulatory roles.